These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26659001)

  • 1. microRNA and Lung Cancer.
    Del Vescovo V; Denti MA
    Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
    PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
    Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
    Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy.
    Naeli P; Yousefi F; Ghasemi Y; Savardashtaki A; Mirzaei H
    Curr Mol Med; 2020; 20(2):90-101. PubMed ID: 31573883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
    Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
    Kruglyak KM; Lin E; Ong FS
    Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
    Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
    Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
    Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
    Boeri M; Pastorino U; Sozzi G
    Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes in circulating miRNA levels in response to antitumor therapy of lung cancer.
    Ponomaryova AA; Morozkin ES; Rykova EY; Zaporozhchenko IA; Skvortsova TE; Dobrodeev АY; Zavyalov AA; Tuzikov SA; Vlassov VV; Cherdyntseva NV; Laktionov PP; Choinzonov EL
    Exp Lung Res; 2016; 42(2):95-102. PubMed ID: 26986825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on sputum MicroRNAs in lung cancer diagnosis.
    Sheervalilou R; Ansarin K; Fekri Aval S; Shirvaliloo S; Pilehvar-Soltanahmadi Y; Mohammadian M; Zarghami N
    Diagn Cytopathol; 2016 May; 44(5):442-9. PubMed ID: 26865409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
    Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
    Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.